Poolbeg Pharma (POLB) Ord Shares
0.05p
(0.53%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.05p
(0.53%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.05p
(0.53%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
9.35p
9.50p
10.85p
£46.50 million
9.35p
9.14p
6.00p
n/a
0.10p (1.08%) Previous:
0.10p
266,648
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2022 | 31/12/2021 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (4.78) | (2.34) |
| Adjusted EPS (p): | (0.94) | (0.74) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Poolbeg gets notice of a new Japan patent
20 September 2023 12:16
-
Poolbeg reports progress with oral vaccine development
22 June 2023 14:47
-
Poolbeg expands its focus molecule into oncology
16 January 2023 15:48
-
Directorate Change
30 November 2023 07:00
-
Former Amryt Pharma Leadership Team join Poolbeg
9 November 2023 07:00
-
POLB001 Data to be Presented at ASH Annual Meeting
3 November 2023 07:05
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.